Medicare Enrolled
Dr. Abhishek Polavarapu, MD
Gastroenterology · Cincinnati, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Polavarapu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Polavarapu?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Polavarapu
Dr. Abhishek Polavarapu is a gastroenterology specialist in Cincinnati, OH, with 12 years of NPI registration. Based on federal Medicare data, Dr. Polavarapu performed 11,127 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Polavarapu received a total of $6,550 from 32 pharmaceutical and/or device companies across 311 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Polavarapu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years of NPI registration
▲ Top 1% volume in OH
$6,550 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗11,127
Medicare services
Top 1% in OH for gastroenterology
Not available
Unique patients (not deduplicated)
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
10,500 | $1 | $2 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
105 | $45 | $963 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
102 | $47 | $636 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
94 | $197 | $1,178 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
73 | $60 | $112 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
67 | $101 | $250 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
27 | $60 | $162 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
26 | $98 | $212 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
26 | $37 | $60 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
25 | $84 | $162 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
25 | $131 | $314 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
17 | $46 | $120 |
| Esophageal dilation with guide wire and endoscope A flexible endoscope is used to insert a guide wire into the esophagus, followed by dilation to widen the esophageal passage. |
15 | $56 | $702 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
13 | $1 | $5 |
| Injection beneath large bowel lining via endoscope A flexible endoscope is used to inject medication or fluid beneath the lining of the large intestine. |
12 | $12 | $704 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
94.5% high complexity
2.1% medium
3.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,550
Total received (2021-2024)
Avg $1,637/year across 4 years
Top 28% in OH for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
311
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,406
2023
$2,136
2022
$1,594
2021
$413
Payments by company (2024)
ABBVIE INC.
$876
Janssen Biotech, Inc.
$262
Lilly USA, LLC
$233
Gilead Sciences, Inc.
$218
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$192
Takeda Pharmaceuticals U.S.A., Inc.
$96
GENZYME CORPORATION
$76
Madrigal Pharmaceuticals
$63
Celgene Corporation
$62
Ardelyx, Inc.
$51
Regeneron Healthcare Solutions, Inc.
$49
Phathom Pharmaceuticals, Inc.
$34
E.R. Squibb & Sons, L.L.C.
$33
AIMMUNE THERAPEUTICS, INC.
$32
IRONWOOD PHARMACEUTICALS, INC
$28
Sandoz Inc.
$22
Organon Llc
$22
QOL Medical, LLC
$21
Celltrion USA Inc.
$18
Fresenius Kabi USA, LLC
$17
Top 3 companies account for 57.0% of 2024 payments
All-time payments by company (2021-2024) ›
ABBVIE INC.
$2,329
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$573
Takeda Pharmaceuticals U.S.A., Inc.
$489
Gilead Sciences, Inc.
$470
Janssen Biotech, Inc.
$460
Lilly USA, LLC
$254
Celgene Corporation
$239
Cook Medical LLC
$223
Ardelyx, Inc.
$221
E.R. Squibb & Sons, L.L.C.
$162
QOL Medical, LLC
$149
GENZYME CORPORATION
$147
Organon LLC
$120
BOSTON SCIENTIFIC CORPORATION
$116
Regeneron Healthcare Solutions, Inc.
$81
Madrigal Pharmaceuticals
$63
INTERCEPT PHARMACEUTICALS, INC.
$53
Nestle HealthCare Nutrition Inc.
$52
Ironwood Pharmaceuticals, Inc
$44
Daiichi Sankyo Inc.
$42
Phathom Pharmaceuticals, Inc.
$34
RedHill Biopharma Inc.
$33
AIMMUNE THERAPEUTICS, INC.
$32
IRONWOOD PHARMACEUTICALS, INC
$28
Sandoz Inc.
$22
Organon Llc
$22
Celltrion USA Inc.
$18
Fresenius Kabi USA, LLC
$17
AbbVie Inc.
$16
Braintree Laboratories, Inc.
$16
Merck Sharp & Dohme Corporation
$13
Intercept Pharmaceuticals, Inc.
$12
Top 3 companies account for 51.8% of all-time payments
Associated products mentioned in payments ›
CREON · DIFICID · DUPIXENT · ECHOTIP · ENTYVIO · EXALT · Epclusa · GATTEX · HADLIMA · HEMOSPRAY · HYRIMOZ · IBSRELA · IDACIO · INJECTAFER · LINZESS · Linzess · MAVYRET · OCALIVA · OMVOH · REMICADE · RENFLEXIS · RESMETIROM · REZDIFFRA · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUTAB · Sucraid · TREMFYA · TRULANCE · Talicia · VIBERZI · VOQUEZNA · Vemlidy · XIFAXAN · ZENPEP · ZEPOSIA · ZYMFENTRA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Gastroenterologists in nearby ZIP areas
119
County median income
$70,816
Nearest hospital to ZIP centroid (approximate)
UNIVERSITY OF CINCINNATI MEDICAL CENTER, LLC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Polavarapu is a mixed practice specialist, with above-average Medicare volume (top 1% in OH).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Polavarapu experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Polavarapu performed 10,500 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Polavarapu receive payments from pharmaceutical companies?
Yes. Dr. Polavarapu received a total of $6,550 from 32 companies across 311 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Polavarapu's costs compare to other gastroenterologists in Cincinnati?
Dr. Polavarapu's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Polavarapu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Cincinnati
Browse gastroenterologists in Cincinnati ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in OH
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in OH
Which OH gastroenterologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology